C. Yilgwan

Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study).

S. Yusuf, A. Haileamlak, G. Karthikeyan, 2016, Circulation.

NUTRITIONAL STATUS AND MORBIDITY IN CHILDREN 0-5 YEARS SEEN IN JOS UNIVERSITY TEACHING HOSPITAL

S. Okolo, C. Yilgwan, O. Ige, 2013 .

Rationale, Design, and the Baseline Characteristics of the RHDGen (The Genetics of Rheumatic Heart Disease) Network Study†

A. Damasceno, L. Zühlke, H. Cordell, 2022, Circulation. Genomic and precision medicine.

Clinical screening for heart disease in apparently healthy Nigerian school children

F. Bode‐Thomas, C. Yilgwan, O. Ige, 2014 .

Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases

A. Damasceno, L. Zühlke, B. Keavney, 2022, Clinical Proteomics.

Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study)

L. Zühlke, C. Mondo, A. Mocumbi, 2016 .